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Abstract
Radiomics, artificial intelligence, and deep learning figure amongst recent buzzwords in current medical imaging
research and technological development. Analysis of medical big data in assessment and follow-up of personalised
treatments has also become a major research topic in the area of precision medicine. In this review, current
research trends in radiomics are analysed, from handcrafted radiomics feature extraction and statistical analysis to
deep learning. Radiomics algorithms now include genomics and immunomics data to improve patient stratification
and prediction of treatment response. Several applications have already shown conclusive results demonstrating
the potential of including other “omics” data to existing imaging features. We also discuss further challenges
of data harmonisation and management infrastructure to shed a light on the much-needed integration of
radiomics and all other “omics” into clinical workflows. In particular, we point to the emerging paradigm shift
in the implementation of big data infrastructures to facilitate databanks growth, data extraction and the
development of expert software tools. Secured access, sharing, and integration of all health data, called
“holomics”, will accelerate the revolution of personalised medicine and oncology as well as expand the role
of imaging specialists.
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Key points
 Since 2012, radiomics algorithms have focused on
lesion characterisation and response prediction in
oncology.
 Research advances are expected in deep learning,
data harmonisation, and communication.
 Radiogenomics and radioimmunomics, alone or in
combination with other data, improve prediction
accuracy.
 Radiomics is a component of all omics data
(holomics) for personalised decision-making.
 This major evolution relies heavily on information
technology and medical imaging specialists.
Background
Radiomics is now a field of intense research after 7 years
of an exponential growth in publications. Radiomics offers
the perspective to augment human perception with the
use of agnostic analyses [1] and even artificial intelligence
with computer-assisted increase in productivity. Naturally,
this trend has been met with great enthusiasm and even
greater scepticism. As the field matures, numerous initia-
tives have led to the development of a growing number of
software solutions, libraries, and algorithms.
Radiomics is of course not the first “omics” field, and
genomics can be traced back to the late 1980s [2], followed
by many others (Fig. 1). The suffix “omics” has long been
used in life sciences to describe the techniques and data in
a specific research field. In the case of radiomics, this suffix
reflects the intent to comprehensively use the data provided
in the medical images with mathematical and statistical ap-
proaches. As radiomics attempts to make its way into the
clinical workflow, the use of imaging data alone is becom-
ing insufficient. While there is no formal proof that clinical
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decisions based on the combination of imaging and other
“omics” data have an impact on clinical outcome, there is
no reason to limit the scope of algorithms. This approach is
similar to clinical practice, where all available data about a
particular patient and previous knowledge from other cases
are aggregated in the decision process. Radiomics-based
algorithms may hence combine genomics, immunomics or
other clinical data to improve diagnostic accuracy.
In an ambitious paradigm shift, radiomics may further
be integrated as a component of a comprehensive soft-
ware system for clinical decision support combining all
“omics” and clinical data into a “holomics” approach
(“holo” meaning “whole” in classical Greek), similarly to
systems biology in experimental research [3, 4].
Widespread adoption of radiomics in the clinical deci-
sion process has been elusive despite a crucial need for
prediction of treatment response and therapy manage-
ment in the era of personalised medicine. With the devel-
opment of large health networks and personalised health
initiatives, the clinical data flow is rapidly expanding
beyond what individual physicians can handle. Through
their growing expertise in complex algorithms, big data
management, and data harmonisation, medical and infor-
mation technology imaging specialists are now key for the
integration of radiomics and holomics in the clinical
workflow of hospitals and health networks (Fig. 2).
This review summarises current research on radiomics
with a focus on standardisation strategies developed to
ensure reproducibility between studies, machines and
centres. It also discusses biobanks and personalised
medicine initiatives in order to illustrate the steps re-
quired for the integration of radiomics into holomics
and, ultimately, into clinical workflows.
Research trends in radiomics
Publication trend
Radiomics aims to capture the informative content hid-
den in medical images, overcoming the limitations of the
human eyes and human cognitive patterns: the rationale
is that medical images (anatomical, functional, or meta-
bolic) can carry information about the physiological
response to cancer and therapy stress [1]. The wealth of
relevant information provided by medical images is key
in decision-making and follow-up of treatment response.
The ability to extract more quantitative data from med-
ical images will reinforce the position of medical imaging
in clinical decision-making and patient management.
Medical and information technology imaging specialists
have produced a number of algorithms, statistical analyses,
and models, fuelling an exponential growth in the number of
publications since 2012 (Fig. 3, Additional file 1: Table S1).
These have gradually become more complex and study more
diverse pathologies, modalities, and applications.
While radiomics make their way into clinical workflows,
large or even dynamically growing prospective patient co-
horts are required to reach the level of robustness and pre-
cision needed to be adopted by clinicians (Fig. 4). To better
understand these challenges, it is important to grasp the
workflow of radiomics, as well as the variety of algorithms
and analytical models currently under development.
Handcrafted radiomics techniques in radiomics research
The current state-of-the-art approach in radiomics relies
on a relatively conventional image analysis workflow,
which is referred to as “handcrafted” radiomics based on
four successive processing tasks [5]: (1) image acquisi-
tion/reconstruction, (2) image segmentation, (3) feature
extraction and quantification, and (4) feature selection/
statistical analysis. In handcrafted radiomics, image fea-
tures are known and are selected depending on their
correlation with clinical outcome.
Image acquisition (step 1) and image segmentation
(step 2) have been a lesser focus of radiomics publi-
cations. However, the risk of bias and potential lack
of reproducibility of algorithms across different ma-
chines, protocols, and sites are well recognised [6–9]
and standardisation issues are further discussed in
the next section.
Feature extraction (step 3) in handcrafted radiomics has
established several techniques based, for example, on image
morphology, histograms, textures, wavelet, or fractal tech-
niques, with their application in original works reviewed in
Fig. 1 Timeline of the first occurrence of selected “omics” terms
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detail by Avanzo et al. [10]. In the same review, the authors
showed that statistical analysis/feature selection (step 4) has
not reached a disease-specific or technical consensus on fea-
ture selection strategies, predictive models and performance
estimation techniques. Linear regression models were shown
to be more frequently used, which can be explained by more
simple models providing graphical results (nomograms)
[11], and a similar trend is noted in a 2019 sample of publi-
cations analysed (Additional file 1: Table S2). Avanzo et al.
[10] further identified limitations of radiomics related to the
size of the cohorts, and issues of standardisation and bench-
marking, which are discussed in the next paragraphs.
The emerging role of deep learning
Deep learning radiomics (DLR) can be applied to any as-
pect of the workflow described above. Many studies use
DLR to either automatically identify or extract features
(step 3). In other instances, a classical handcrafted radio-
mics approach extracts features so that a DLR algorithm
can select them (step 4). Single artificial neural networks
(ANN) can perform both tasks [5].
DLR is based on a subtype of machine learning tech-
nique based on ANN with a high number of intercon-
nected layers. Given a training set, such networks can
autonomously build image filters and extract image
Fig. 2 Illustration of the different elements of a model of integration of radiomics in a holomics-based clinical workflow. Patients: constant
accumulation of patient data is used in a dynamic model. Examinations: images are produced with many protocols, machines, and facilities.
Other "omics" data from blood tests, tumour samples, or clinical data are aggregated. Image vault/data centre: a collaborative, open-source, open
data storage infrastructure guarantees secured ownership of data, and facilitated software development. Harmonisation/quality control: as for
other omics, radiomics can only reach clinical practice and feed algorithms with harmonisation and quality control at each step. Decision:
predictive information (rather than prognostic only) is provided to tumour boards or other specialist boards to provide support for decision
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features for classification without the need to pre-
determine (handcraft) them. In the field of medical im-
aging, several applications have already been successfully
designed, for example, in detecting lung nodules [12] or
in building computed tomography images from magnetic
resonance images for the purpose of positron-emission
tomography (PET) attenuation correction [13].
These multi-layer ANN are often convolutional (cANN)
or recurrent (rANN) and, after training, produce image
filters and features in a much higher number than other
techniques. The major challenge of deep learning algo-
rithms in radiomics is however the need for a higher num-
ber of observations (patients) than in many handcrafted
radiomics studies.
However, once trained, a deep learning algorithm can
be extremely fast and accurate [5]. Recently, Xu et al. [14]
have developed a model based on a cANN and a rANN
for overall survival prognosis in non-small cell lung cancer
using a seed point tumour localisation instead of a clas-
sical segmented contour. The authors analysed how the
tumour evolved during the time, exploiting several succes-
sive computed tomography scans acquired at different
time points (pre-treatment, 1, 3, and 6months after radi-
ation therapy). Algorithms that can include multiple im-
aging time points are a key step to bring radiomics to the
bedside and into personalised oncology data streams.
Fig. 3 Timeline of the occurrence of radiomics publications from
PubMed title and abstract search shows exponential growth since
2012 with a slowdown in early 2019
Fig. 4 Research trends in radiomics from a sample of the first radiomics 40 papers of 2018 (white) and 2019 (grey) show a shift towards more
diverse applications and larger cohorts of patients (see Additional file 1: Table S1 for PubMed query syntax). a Trial type. b Study aim. c Total size
of cohort. d Disease type. e Imaging modality. CT Computed tomography, MRI Magnetic resonance imaging, PET Positron emission tomography,
US Ultrasound
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Protocol standardisation in radiomics feature
extraction
A fundamental aspect of radiomics is the capability of
extracting quantitative image features (QIFs). QIFs are
measures computed directly from the voxel values (inten-
sity) and their spatial organisation (shape and texture).
When compared to human-based visual analysis and
semantic (i.e., text) features, the main advantage of QIFs is
to yield more objective and reproducible image analysis.
However, this advantage comes with the following two
challenges.
First, small changes in voxel values can lead to strong
variation in values of QIFs, which in turn can modify the
output of the associated predictive model and lead to in-
adequate classification.
Second, the definition, implementation and semantic
grouping of QIFs can vary between scanners, studies,
and software, which hinders the interoperability of QIFs
and their interpretation [15]. These aspects are of par-
ticular importance for the integration of radiomics in
clinical workflows. Both individual patients and patient
cohorts may be managed in multiple centres and may
benefit from medical imaging from different scanners
and different imaging protocols.
The impact and potential solution to address the two
aforementioned challenges are hence of particular interest.
Standardisation of feature definition
The very first aspect of standardisation is to establish a
common reference of the definitions of every QIFs. Second,
it must be ensured that distinct software implementation of
the same QIF will provide the same measure for a given in-
put. To address these two aspects, the Image Biomarker
Standardisation Initiative (IBSI) did a remarkable and
exhaustive effort, where the QIF definitions are organised
in a reference manual [6]. In addition, the IBSI defined a
systematic benchmarking of radiomics software using syn-
thetic and patient-based reference images, which allowed to
achieve consensus for most QIFs, but often after several
iterations of discussions, debug and re-implementation,
showcasing the importance of the initiative. The description
and benchmarking were not limited to QIFs, but also to
image pre-processing and interpolation steps. Since most
radiomics software and researchers joined the IBSI since
September 2016, it will have a significant impact on the
reproducibility of future radiomics studies and the inter-
operability of QIF extraction algorithms.
Impact of imaging protocol on QIFs: towards
standardisation and invariance
Imaging protocols relate to image acquisition and recon-
struction and are depending on many factors including
disease, anatomical regions and manufacturers and user
preferences. Expert image readers are able to quickly
adapt to changes in image quality and reconstruction
parameters. However, because QIFs are computed from
raw voxel values, changing acquisition protocols will
have a direct influence on the extracted quantitative
measures. This can be simply illustrated with the max-
imum standardised uptake value (SUVmax), which mea-
sures the maximum uptake in PET imaging and was
identified in many radiomics studies as an important
biomarker [16, 17]. SUVmax will vary significantly based
on the post-reconstruction smoothing of PET images
(e.g., Gaussian filtering), which deteriorates the generalisa-
tion performance of a SUVmax-based radiomics model
between imaging centres using different reconstruction
protocols. Although achieving consensus protocols across
all imaging departments and manufacturers is still unrealis-
tic today, systematic studies of their impact on feature
values are crucial to determine the deployment success of
radiomics-based clinical models.
Traverso et al. [18] reviewed 41 studies focusing on
repeatability and reproducibility of QIFs. Repeatability is
defined as QIF stability when imaging the same subject
(or phantom) over time and is often associated with the
test-retest methodology [19]. Reproducibility addresses
the stability of QIFs across imaging conditions (protocol,
manufacturer) and is therefore more general than repeat-
ability. The survey revealed that although no consensus
could be found regarding the most repeatable and repro-
ducible features, intensity (also called first-order) features
were in general more reproducible than shape and textural
QIFs.
As a further step towards reproducibility, several efforts
focused on developing QIF transformations to achieve in-
variance to imaging protocols. A notable example is the use
of the Combat method (initially developed in the context of
genomics to remove machine and time variability in micro-
array data using Bayesian statistics [20]) to successfully
standardise PET radiomics [21]. Neural networks and deep
learning techniques such as generative adversarial networks
were used in [22] to learn QIF transforms that makes them
independent to scanner manufacturers and protocols. The
transforms were learnt based on the Credence Cartridge
Radiomics (CCR) physical phantom and associated dataset
resulting from scanning with various imaging conditions.
This radiomics-specific imaging phantom is made of 10
cartridges filled with various materials leading to a wide
range of values of radiomics features [23].
Integration of omics data with radiomics
algorithms
While a definitive proof that combining all omics infor-
mation can result in better precision in predicting clin-
ical outcome is not easily achievable, it is important to
note that this approach is commonly used in patient
management: physicians gather available information
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from various diagnostic and examination techniques
prior to devising a specific patient management plan.
Similarly, radiomics has witnessed an evolution from an
initial focus on lesion identification (such as malignant
versus non-malignant lesions) and prognosis (i.e., assessing
disease but not therapy). In more recent algorithms, gen-
omic or immunomic features are used to address treatment
selection or response (i.e., predictive rather than prognostic)
and to improve prediction of clinical outcomes (such as
overall survival or toxicity) [24, 25]. These approaches can
be described specifically as radiogenomics, respectively
radioimmunomics. Furthermore, the term holomics is used
to refer to more ambitious strategies where radiomics is
one component of all “omics” axes used for clinical man-
agement in precision medicine strategies [26].
Radiogenomics
The pioneer work of Gevaert et al. in 2012 opened the
field of radiogenomic by studying the correlation of gene
clusters with radiomics features in 26 non-small cell lung
cancer [27]. The following year, Aerts et al. published one
of the earliest studies correlated with genetic information
[28]. In this milestone publication, the inclusion of more
than 1,000 patients with lung or head and neck cancer led
to a four-feature prognostic score. Interestingly, prognos-
tic capability of the signature was maintained between
tumour subtypes and in particular regardless of human
papillomavirus (HPV) status of head and neck tumours.
Gene-set enrichment analysis was used to correlate (and
not predict) each feature with gene expression, inferring
for example a relationship between tumour heterogeneity
on imaging and cellular proliferation.
More recently, Digumarthy et al. showed that the combin-
ation of clinical, imaging and radiomics features can separate
epidermal growth factor receptor mutant from wild-type
lung adenocarcinoma with high accuracy [29]. The technical
survey published in 2017 by Incoronato et al. explored the
status of radiomics research on the correlation and/or pre-
diction of genomic characteristics in 55 original research
publications [25]. Incoronato et al. showed that correlation
models were twice most frequent and that they were heavily
reliant on statistical methods rather than machine learning
with a majority of canonical standard models (Wilcoxon,
chi-squared, Fisher’s test, Kruskal-Wallis), of canonical cor-
relation techniques (Spearman, Pearson) and linear-
regression based techniques (linear-regression, logistic re-
gression, etc.). Deep learning approaches have also shown
successes in predicting gene expression and mutation status
in gliomas [30–32].
This field remains in constant expansion and further re-
views such as Pinker et al. and El Naqa et al. analyse the
current state of the art in multiple cancers combining radio-
mics with single nucleotide polymorphisms, copy number
variations and gene expression amongst others [33, 34].
Radioimmunomics
Immune checkpoint modulation and other immunother-
apies have significantly increased therapeutic options in
oncology and lead to a need for better predictive tools for
therapy management decisions and better response follow-
up [35]. The recent field of radioimmunomics is expected to
further develop in the future. In current publications, the
work of Sun et al. is of particular interest. The team devel-
oped a predictive radiomics model focusing of immunomics
(CD8, cell infiltration in solid tumours) and subsequent
response to immune checkpoint therapy (anti-PD-1 or anti-
PD-L1) [36]. Interestingly, this retrospective work on four
cohorts of above 100 patients each did not restrict itself to a
single tumour histology but used databases of patients with
solid tumours. It used computed tomography images to
build a radiomics biomarker of CD8 cells infiltration (using
transcription of CD8B ribonucleic acid in biopsy samples)
which showed prediction power for response to immuno-
therapy. This handcrafted radiomics study was based on ma-
chine learning (not deep learning) using a linear elastic-net
model with 78 radiomics and six additional features (peak
voltage and five binary location variables).
Data heterogeneity in holomics
The challenge of data heterogeneity becomes critical when
combining radiomics approaches with genomic or immu-
nomic data or when building holomics workflows. The data
contained in an imaging study (voxels values, protocols,
series, etc.) is neither numerical (i.e., a single continuous
number) nor categorical (i.e., positive versus negative, low
versus moderate versus high). Many radiomics strategies are
based on statistical methods in order to reduce the dimen-
sionality of image data by focusing on individual continu-
ous numerical variables (i.e., the features themselves). In
deep learning, popular techniques such as convolutional
ANN (cANN) are able to acquire in input the whole image,
exploit the informative content of the pixel/voxel proximity,
and automatically build representative image features and
filters to reduce the noise due to signal ratio. However,
cANN have been developed specifically for images and
incorporating individual numerical or categorical variables
(ECG signals, lab tests, pathology results) adds further com-
plexity. More recently, ensemble learning has been intro-
duced to combine several predictors that use different data
types [37, 38]. Ensemble learning is widely adopted in other
domains (e.g., information retrieval, where a meta-predictor
is built by voting on different predictors [39]).
Big data challenges for precision medicine
Challenges of health and imaging biobanks
The developments of imaging biobanks and cloud-based
data storage services have radically changed the way in
which communication and data management are dealt
with. Online storage of medical images is not new; several
Gatta et al. European Radiology Experimental            (2020) 4:11 Page 6 of 9
vendors have offered such services for decades already as
part of their commercial solutions [39, 40]. Recently, a
major change is the emergence of widely accessible and
attractive services at a very low cost. These developments
face more hurdles in medical applications, due to strict
regulations and guidelines for patient confidentiality and
data security.
The wealth of data acquired in clinical routine these
days is overwhelming and has not been apprehended
yet; medical images are no exception.
A crucial limiting factor in the development of radio-
mics for large and open cohorts in order to be applicable
in clinical workflows is the lack of open and collabora-
tive infrastructure collecting constantly structured and
well-documented imaging data [41]. Restrictive regula-
tory constraints and data protection rules further pre-
vent the usage and exploitation of medical data without
formal patient approval. Overall, the walls between med-
ical institutions, medical records, and all clinical data re-
positories have remained despite multiple initiatives from
individual institutions, professional societies, and private
corporations to facilitate the accessibility to the data. Data
extraction and anonymisation for open-access databanks
is indeed still very limited [42].
Recent years have seen the development of international
consortia and networks to facilitate sample collection and
distribution to allow access to precious biomaterials and
medical data from patients [43]. Such repositories should
provide open access to carefully curated and annotated
data. These initiatives however face many challenges that
have been long-recognised and theorised [44, 45]. He iden-
tified the key restrictions to the development of an open re-
pository to harbour radiomics tools and computer-aided
personalised medicine.
Despite these initiatives, many hurdles remain. Data
collection is complex due to institutional, infrastructure
and regulatory issues. Further, ownership of data by the
source institution and the patient is not guaranteed from
data collection to utilisation, in particular as data itself
may be considered the source of value. This issue is a
major difficulty to reach broad acceptance and clinical
application. We hypothesise that it may be circumvented
by adopting open source and open data architectures as
these systems benefit from wide acceptance. Finally, as
databases grow, software tools that incorporate new data
need to be developed, in particular based on deep learn-
ing approaches within environments that facilitate soft-
ware development.
Initiatives for precision medicine
In parallel, there is a significant attempt by national au-
thorities and private initiatives to channel the amount of
data to better predict disease occurrence and behaviour,
guide therapy management, and predict outcome.
Amongst these, notably the National Institute for Health
(NIH) has launched the “All of Us” research programme
aiming at accumulating data on over a million partici-
pants. Further research initiatives in the USA towards pre-
cision medicine in oncology have been developed in the
past decade by the National Cancer Institute. The NCI ini-
tiative has designated cancer imaging as one of the four
principal axes of this initiative along translational research,
genomics and immunomics.
Switzerland has initiated a nationwide initiative for the
support and development of personalised medicine
called the “Swiss Personalized Health Network” [46]
aimed at the harmonisation and deployment of large
networks of information technology infrastructures and
data repository for future support of artificial intelligence
and computer-aided medical decisions and personalised
patient management. Notably, within this initiative, a
global ethics approval across adopted by each Swiss uni-
versity hospital is being implemented [47].
Amongst several initiatives currently underway to sus-
tain the development of such networks, a new platform
is being specifically designed for hosting and sharing
medical imaging data for the implementation of machine
learning and radiomics tools. This open platform, called
KHEOPS [48], offers a flexible solution for storing, shar-
ing and viewing medical images. KHEOPS is an open-
source project with the source code available on GitHub
which provides the framework for secure and flexible
management of extensive collections of digital images in
open and scalable infrastructure for storage, communi-
cation, wide distribution, processing, and analysis of this
data. In an intermediate step to circumvent data owner-
ship and privacy issues, initiatives to federate research
centres around multiple data sources and data types (in-
cluding images) are already established, such as VATE
[49] and EuroCAT [50]. As opposed to KHEOPS, these
are based on distributed learning, where each institution
maintains a databank and only shares data aggregation.
Conclusions
With the development of radiomics as a mainstream re-
search field, major efforts have been undertaken in the
development of new algorithms. In recent years, radioge-
nomics, radioimmunomics, or other clinical data have
been used to increase predictive capacity and accuracy.
Concerted efforts and initiatives aiming for data har-
monisation between imaging protocols, scanners and
imaging devices as well as quality control of algorithms
being used for feature extraction are also well underway.
As the field has now matured, the shift from individual
algorithms engineered (handcrafted) from finite datasets
(i.e., patient cohorts) to open tools that dynamically inte-
grate the constant inflow of medical data is paramount.
However, reaching this goal has so far remained elusive,
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despite many initiatives from institutions, professional
societies, manufacturers, and major information technol-
ogy and Internet corporations.
The time has hence come for a paradigm shift. The
imaging and clinical databases can only thrive if data ex-
traction itself is facilitated and if institutional and patient
ownership is extended to every stage of data indexing, stor-
age, and analysis. Further, mirroring the dynamic nature
that should be adopted by these databases, radiomics, and
other software tool development have to be facilitated. The
whole environment must embrace full web application pro-
gramming interfaces, dematerialised data storage, and pro-
vide persistent and secure data ownership. We believe that
such infrastructure can be achieved with the confidence
that offers open source and open data technologies.
It will provide the backbone for thriving, evolutive and
collaborative radiomics and holomics tools to ultimately
reach clinical workflows. The medical imaging commu-
nity has the opportunity and responsibility to lead these
developments in order for precision medicine based on
comprehensive holomics computer-assisted expert sys-
tems to mediate a revolution in medical practice and pa-
tient management.
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